Strengthening Research and Technological Development Capabilities and Establishing a Pioneering Research System
First written in FY2016-Q3. 24 of 33 entries say "Restated". Latest entry: 2026-06-13.
11 other companies' latest entry also says "Advanced".
- FY2025-H1RestatedAnnual report
「The Group's total research and development expenditure during the six-month interim period was ¥2,812 million. There were no material changes in the status of the Group's research and development activities during the six-month interim period.」
Research and development expenditure for the interim period was ¥2,812 million, with no material changes in the status of research and development activities. - FY2024AdvancedAnnual report
「長谷川香料（上海）有限公司 is using the new research building, completed in November 2023, to its fullest extent to strengthen its research and development capabilities and improve operational efficiency.」
Research and development expenditure was ¥5,549 million, with 374 researchers. The new research building of the Chinese subsidiary was completed in November 2023, and the company is moving toward using it to strengthen research and development capabilities and improve operational efficiency. - FY2024-Q2RestatedAnnual report
「The Group's total research and development expenditure during the six-month period ended in the second quarter was ¥2,642 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended in the second quarter.」
The company recorded research and development expenditure of ¥2,642 million, with no material changes in the status of research and development activities. - FY2024-Q1RestatedAnnual report
「The Group's total research and development expenditure during the six-month period ended in the first quarter was ¥1,349 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended in the first quarter.」
First-quarter research and development expenditure was ¥1,349 million, with no material changes in the status of research and development activities. - FY2023AdvancedAnnual report
「Research and development expenditure for the fiscal year was ¥5,247 million in total, comprising ¥3,629 million in Japan, ¥796 million in Asia and ¥820 million in the United States. As of 30 September 2023, the Group had 358 researchers.」
Research and development expenditure increased from ¥4,971 million in the previous fiscal year to ¥5,247 million, while the number of researchers decreased from 363 to 358. The company also specified collaboration among its research institutes and the research divisions of overseas subsidiaries, the use of external expertise and open innovation. - FY2023-Q3Change in the scope of responsibility for the research divisionAnnual report
「The Group's total research and development expenditure during the nine-month period ended in the third quarter was ¥3,828 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended in the third quarter. Director and Senior Executive Officer, head of the research division, deputy head of the Quality Assurance Department and Business Solutions Planning Office, responsible for the Technology Research Institute, Flavor Research Institute, Fragrance Research Institute, Research Planning Department and Research Administration Department, head of the Central Research Institute」
Although there were no material changes in the research and development activities themselves, the Research Administration Department was added to the scope of responsibility in the executive appointment changes dated 19 June 2023. Research and development expenditure was ¥3,828 million. - FY2023-Q2RestatedAnnual report
「The Group's total research and development expenditure during the six-month period ended in the second quarter was ¥2,528 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended in the second quarter.」
Research and development expenditure for the six-month period ended in the second quarter was ¥2,528 million, with no material changes in the status of research and development activities. - FY2023-Q1RestatedAnnual report
「The Group's total research and development expenditure during the six-month period ended in the first quarter was ¥1,318 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended in the first quarter.」
The company recorded research and development expenditure of ¥1,318 million, with no material changes in the status of research and development activities. - FY2022RestatedAnnual report
「Research and development expenditure for the fiscal year was ¥4,971 million in total, comprising ¥3,508 million in Japan, ¥717 million in Asia and ¥746 million in the United States. As of 30 September 2022, the Group had 363 researchers, comprising 251 in Japan, 85 in Asia and 27 in the United States.」
The company has a research and development structure with ¥4,971 million in research and development expenditure and 363 researchers, and continues to operate this structure. - FY2022-Q3RestatedAnnual report
「The Group's total research and development expenditure during the nine-month period ended in the third quarter was ¥3,636 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended in the third quarter.」
Research and development expenditure for the nine-month period ended in the third quarter was ¥3,636 million, with no material changes in the status of research and development activities. - FY2022-Q2RestatedAnnual report
「The Group's total research and development expenditure during the six-month period ended in the second quarter was ¥2,396 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended in the second quarter.」
Research and development expenditure for the six-month period ended in the second quarter was ¥2,396 million, with no material changes in the status of research and development activities. - FY2022-Q1RestatedAnnual report
「The Group's total research and development expenditure during the six-month period ended in the first quarter was ¥1,230 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended in the first quarter.」
First-quarter research and development expenditure was ¥1,230 million, with no material changes in the status of research and development activities. - FY2021AdvancedAnnual report
「The Group's research and development activities are conducted primarily through its Central Research Institute under the Business Solutions Division, established in October 2020 to strengthen coordination among sales, research and marketing. The Central Research Institute comprises the Technology Research Institute, which develops fragrance and food ingredients and conducts research into the functions and added value of fragrances, and the Flavor Research Institute and Fragrance Research Institute, which conduct perfumery research for commercialization and applied research for customers' products. By facilitating collaboration among the institutes, the Group seeks to further strengthen its research and technological development capabilities.」
The company has integrated collaboration among research, sales and marketing under the Business Solutions Division, with research and development expenditure of ¥4,675 million and 366 researchers. - FY2021-Q3RestatedAnnual report
「The Group's total research and development expenditure during the nine-month period ended in the third quarter was ¥3,442 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended in the third quarter.」
Research and development expenditure for the nine-month period ended in the third quarter was ¥3,442 million, with no material changes in the status of research and development activities. - FY2021-Q2RestatedAnnual report
「The Group's total research and development expenditure during the six-month period ended in the second quarter was ¥2,121 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended in the second quarter.」
Research and development expenditure for the six-month period ended in the second quarter was ¥2,121 million, with no material changes in the status of research and development activities. - FY2021-Q1RestatedAnnual report
「The Group's total research and development expenditure during the six-month period ended in the first quarter was ¥1,128 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended in the first quarter.」
Research and development expenditure for the quarter was ¥1,128 million, with no material changes in the status of research and development activities. - FY2020AdvancedAnnual report
「The Group's research and development activities are conducted primarily through its Central Research Institute. In October 2019, the Group reviewed its organizational structure to further accelerate research and development. The Central Research Institute comprises the Technology Research Institute, which develops fragrance and food ingredients and conducts research into the functions and added value of fragrances, and the Flavor Research Institute and Fragrance Research Institute, which conduct perfumery research for commercialization and applied research for customers' products. By facilitating collaboration among the institutes, the Group seeks to further strengthen its research and technological development capabilities.」
The company reviewed its research and development structure in October 2019 to accelerate research and development. Research and development expenditure is ¥4,523 million, with 350 researchers. - FY2020-Q2RestatedAnnual report
「The Group's total research and development expenditure during the six-month period ended in the second quarter was ¥2,200 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended in the second quarter.」
The company recorded research and development expenditure of ¥2,200 million, with no material changes in the status of research and development activities. - FY2020-Q1RestatedAnnual report
「The Group's total research and development expenditure during the six-month period ended in the first quarter was ¥1,134 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended in the first quarter.」
First-quarter research and development expenditure was ¥1,134 million, with no material changes in the status of research and development activities. - FY2019-Q3RestatedAnnual report
「The Group's total research and development expenditure during the nine-month period ended in the third quarter was ¥3,357 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended in the third quarter.」
Research and development expenditure for the nine-month period ended in the third quarter was ¥3,357 million, with no material changes in the status of research and development activities. - FY2019-Q2RestatedAnnual report
「The Group's total research and development expenditure during the six-month period ended in the second quarter was ¥2,228 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended in the second quarter.」
Research and development expenditure for the six-month period ended in the second quarter was ¥2,228 million, with no material changes in the status of research and development activities. - FY2019-Q1RestatedAnnual report
「The Group's total research and development expenditure during the six-month period ended in the first quarter was ¥1,146 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended in the first quarter.」
First-quarter research and development expenditure was ¥1,146 million, with no material changes in the status of research and development activities. - FY2018AdvancedAnnual report
「The Group's research and development activities are conducted primarily through its Central Research Institute. The Aroma Basic Research Institute, which conducts research into fragrance development and the functions and added value of fragrances; the Technology Research Institute, which develops fragrance and food ingredients; and the Flavor Research Institute and Fragrance Research Institute, which conduct perfumery research for commercialization and applied research for customers' products, are organized under the Central Research Institute. By facilitating collaboration among the institutes, the Group seeks to further strengthen its research and technological development capabilities. The Group is also deepening collaboration with the research divisions of its subsidiaries in the United States, China and Malaysia, applying technologies developed in Japan overseas and establishing a structure that enables the Group as a whole to respond promptly to increasingly diverse and sophisticated customer needs.」
In addition to collaboration among the four research institutes, the company has specified collaboration with the research divisions of its subsidiaries in the United States, China and Malaysia. Research and development expenditure is ¥4,507 million, with 343 researchers, expanding the research structure to include overseas applications. - FY2018-Q3RestatedAnnual report
「The Group's total research and development expenditure during the nine-month period ended in the third quarter was ¥3,278 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended in the third quarter.」
The company recorded research and development expenditure of ¥3,278 million, with no material changes in the status of research and development activities. - FY2018-Q2RestatedAnnual report
「The Group's total research and development expenditure during the six-month period ended in the second quarter was ¥2,172 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended in the second quarter.」
The company recorded research and development expenditure of ¥2,172 million, with no material changes in the status of research and development activities. - FY2018-Q1RestatedAnnual report
「The Group's total research and development expenditure during the six-month period ended in the first quarter was ¥1,135 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended in the first quarter.」
The company recorded research and development expenditure of ¥1,135 million, with no material changes in the status of research and development activities. - FY2017AdvancedAnnual report
「To promote strategic research and development with a view to the future, we will identify priority areas and further strengthen research and development by leveraging collaboration among the four research institutes—the Aroma Basic Research Institute, Technology Research Institute, Flavor Research Institute and Fragrance Research Institute. We will also explore unknown possibilities and focus on creating innovation, or technological breakthroughs.」
The company has explicitly stated that it will strengthen research and development and create innovation by leveraging collaboration among the four research institutes. Total research and development expenditure is ¥4,340 million, with 331 researchers. - FY2017-Q3RestatedAnnual report
「The Group's total research and development expenditure during the nine-month period ended in the third quarter was ¥3,168 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended in the third quarter.」
The company recorded research and development expenditure of ¥3,168 million, with no material changes in the status of research and development activities. - FY2017-Q2RestatedAnnual report
「The Group's total research and development expenditure during the six-month period ended in the second quarter was ¥2,109 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended in the second quarter.」
The company recorded research and development expenditure of ¥2,109 million, with no material changes in the status of research and development activities. - FY2017-Q1RestatedAnnual report
「The Group's total research and development expenditure during the six-month period ended in the first quarter was ¥1,052 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended in the first quarter.」
First-quarter research and development expenditure was ¥1,052 million, with no material changes in the status of research and development activities. - FY2016-Q3AdvancedAnnual report
「The Group's total research and development expenditure during the nine-month period ended in the third quarter was ¥3,144 million. On 5 January 2016, the Company reorganized its operations, consolidating the basic research functions of the Technology Research Institute, Flavor Research Institute and Fragrance Research Institute, and establishing the Aroma Basic Research Institute to conduct fundamental research.」
The company recorded research and development expenditure of ¥3,144 million and established the Aroma Basic Research Institute on 5 January 2016 by consolidating its basic research functions.